|No Hedge in Corré’s Message to Law Students:
The Investment Industry Needs You
|1 - 2 - 3 - 4
When Bristol-Myers’ stock plummeted in 2006, following
word of a federal investigation into the company’s efforts to
protect the patent for Plavix, administrators at Eton Park Capital
Management turned to Isaac Corré to determine whether to
keep its shares in the drug company.
Nervous investors wanted to know if the courts would uphold
the patent of the top-selling anticoagulant and prevent a
competitive generic from entering the market.
As it turns out, he made the Corréct call.